Home

Charles A. Deignan

CIK 1664690 · Chief Financial Officer · last filed 2025-01-10

Charles A. Deignan is a Chief Financial Officer who has filed 26 SEC Form 4 insider transactions across 1 company since 2016. The most recent filing, for CLSD, was dated Jan 10, 2025. Across all open-market trades the lifetime net is −$79.9K, making them a net seller over the disclosed history.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

1

Total Filings

26

Lifetime Open-Market Net

-$79.9K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Clearside Biomedical, Inc. (CLSD) Delisted Chief Financial Officer 384,662 $0.35 $135.2K -$79.9K 26 2025-01-10

Recent Filings

26 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2025-01-10 Clearside Biomedical, Inc. (CLSD) Delisted Grant (A) — $0 EDGAR
2024-01-19 Clearside Biomedical, Inc. (CLSD) Delisted Mixed −12,900 -$16.5K EDGAR
2023-09-20 Clearside Biomedical, Inc. (CLSD) Delisted Grant (A) — $0 EDGAR
2023-09-13 Clearside Biomedical, Inc. (CLSD) Delisted Exer (M) +34,090 $13.6K EDGAR
2023-01-20 Clearside Biomedical, Inc. (CLSD) Delisted Sell (S) −14,030 -$21.0K EDGAR
2023-01-06 Clearside Biomedical, Inc. (CLSD) Delisted Grant (A) — $0 EDGAR
2022-12-20 Clearside Biomedical, Inc. (CLSD) Delisted Exer (M) +23,636 $9.5K EDGAR
2022-01-28 Clearside Biomedical, Inc. (CLSD) Delisted Grant (A) +46,250 $0 EDGAR
2022-01-20 Clearside Biomedical, Inc. (CLSD) Delisted Mixed +34,917 -$18.5K EDGAR
2021-09-23 Clearside Biomedical, Inc. (CLSD) Delisted Sell (S) −2,800 -$17.9K EDGAR
Showing 1–10 of 26
Page 1 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.